Ali, Sapya S.
HRN: 10-74-98 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/13/2026
03/19/2026
IV
600 MG
Q8
CELLULITIS
Checking Initial Appropriateness
03/13/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/13/2026
03/20/2026
IV
1.5g
Q6
Furuncle
Checking Initial Appropriateness
03/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2026
03/30/2026
IV
1.5
Q6
Cellulitis
Checking Initial Appropriateness
03/24/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/24/2026
03/31/2026
IV
600 MG
Q6
CELLULITIS
Checking Initial Appropriateness